Company intelligence / Profile preview

DreamJay

Ownership: Private
Development stage: Other

Overview

DreamJay developed "Nightly," a mobile medical application designed to improve sleep quality by playing audio and video content that reduces stress and anxiety, manages bad dreams, and decreases the number of nighttime awakenings. The company focused on non-pharmacological interventions for sleep issues using digital therapeutics. There is no evidence of clinical trial results or regulatory approvals typical for pharmaceutical products.

Therapeutic areas: PsychiatryNeurology
Modalities: Non-pharmacological therapyDevice (mobile app)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on DreamJay.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DreamJay.

Explore the full profile